Defects of the spliceosomal gene SNRPB affect osteo- and chondro-differentiation

Area of Science:

• Molecular Biology
• Developmental Biology
• Genetics

Background:

• Spliceosomal defects, despite occurring widely, manifest in specific tissues.
• Cerebro-costo-mandibular syndrome (CCMS) is a spliceosomal disease linked to SNRPB gene mutations, causing skeletal abnormalities.
• The SNRPB gene encodes Small Nuclear Ribonucleoprotein Polypeptides B/B' (SmB/B'), essential spliceosomal components.

Purpose of the Study:

• To investigate the role of SmB/B' in osteo- and chondro-differentiation using in vitro cell cultures.
• To elucidate the molecular mechanisms by which SNRPB mutations lead to skeletal dysmorphism in CCMS.
• To explore the interplay between SmB/B' levels, Wnt/β-catenin signaling, and BMP pathway activities in skeletal differentiation.

Main Methods:

• Utilized in vitro cell cultures (Saos-2 and HEPM cells) to model osteo- and chondro-differentiation.
• Employed gene knockdown and mutation strategies to alter SmB/B' levels.
• Analyzed the impact on differentiation markers, gene splicing (Dlx5, TCF7L2), and Wnt/β-catenin and BMP pathway activities.

Main Results:

• Reduced SmB/B' levels suppressed osteodifferentiation and affected Dlx5 splicing in osteoprogenitor cells.
• Low SmB/B' levels promoted chondrogenesis in mesenchymal stem cells.
• SNRPB knockdown attenuated Wnt/β-catenin and/or enhanced BMP pathway activities, partly through altered TCF7L2 splicing.

Conclusions:

• This study reveals that reduced SmB/B' expression disrupts skeletal differentiation by modulating Wnt and BMP signaling pathways.
• Altered splicing of key genes like Dlx5 and TCF7L2 contributes to the skeletal phenotypes observed in CCMS.
• Understanding these mechanisms provides insight into spliceosomal disease pathogenesis and potential therapeutic targets.